Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adverum Biotechnlgs
(NQ:
ADVM
)
1.230
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 31, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.230
Bid (Size)
1.210 (5)
Ask (Size)
1.280 (68)
Prev. Close
1.230
Today's Range
1.230 - 1.230
52wk Range
0.5310 - 1.820
Shares Outstanding
98,125,866
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Thursday's Intraday Session
May 25, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
March 07, 2023
Via
Benzinga
Performance
YTD
+92.19%
+92.19%
1 Month
+51.83%
+51.83%
3 Month
+64.00%
+64.00%
6 Month
+83.61%
+83.61%
1 Year
+37.09%
+37.09%
More News
Read More
12 Health Care Stocks Moving In Monday's After-Market Session
November 28, 2022
Via
Benzinga
Adverum Posts New Data From Wet AMD Gene Therapy Trial
July 15, 2022
Via
Benzinga
Adverum Biotechnologies Cuts Workforce, Prioritizes ADVM-022
July 07, 2022
Via
Benzinga
Adverum's Data at ASGCT Further Supports Phase 2 Development Plans For Wet-AMD Gene Therapy
May 18, 2022
Via
Benzinga
Adverum Bio Posts Additional Efficacy, Safety Data From ADVM-022 Gene Therapy In Wet AMD
May 02, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 26, 2022
Via
Benzinga
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
September 14, 2022
Via
Benzinga
Adverum Commences Mid-Stage Chronic Eye Disorder Candidate Study
September 14, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 26, 2022
Via
Benzinga
The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate
July 15, 2022
Via
Benzinga
Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday
July 18, 2022
Via
Benzinga
The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill
July 07, 2022
Via
Benzinga
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
July 15, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
July 07, 2022
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 7, 2022
July 07, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 06, 2022
Via
Benzinga
Short Volatility Alert: Adverum Biotechnologies, Inc.
June 15, 2022
Via
Benzinga
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
June 07, 2022
Via
Benzinga
3 Stocks Under $3 Insiders Are Aggressively Buying
April 25, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 18, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 12, 2022
Via
InvestorPlace
The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More
April 07, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.